Back to Journals » Journal of Multidisciplinary Healthcare » Volume 18
Mental Health Status of Patients with Thyroid Nodules: A Cross-Sectional Study
Authors Wang P, Yan J , He H, Che Y
Received 15 January 2025
Accepted for publication 28 April 2025
Published 9 May 2025 Volume 2025:18 Pages 2641—2650
DOI https://doi.org/10.2147/JMDH.S513795
Checked for plagiarism Yes
Review by Single anonymous peer review
Peer reviewer comments 3
Editor who approved publication: Dr Jacqueline Dunbar-Jacob
Peng Wang,1,* Jing Yan,2,* Honghai He,1 Ying Che1
1Medical Examination Center, Peking University Third Hospital, Beijing, People’s Republic of China; 2Peking University Sixth Hospital, Peking University Institute of Mental Health, NHC Key Laboratory of Mental Health (Peking University), National Clinical Research Center for Mental Disorders (Peking University Sixth Hospital), Beijing, People’s Republic of China
*These authors contributed equally to this work
Correspondence: Ying Che, Medical Examination Center, Peking University Third Hospital, North Garden Road & 49, Beijing, People’s Republic of China, Email [email protected]
Purpose: This study aims to investigate the mental health status of patients with high-risk and low-risk thyroid nodules (TNs), and the potential psychological risk factors that may exist in patients with high-risk nodules.
Patients and Methods: In this cross-sectional study, a total of 7645 adults who participated in physical examinations from January 2021 to December 2023 were included. During the physical examination, they all completed thyroid ultrasound examinations and laboratory tests, and filled out self-administered questionnaires, as well as the Symptom Checklist-90 (SCL-90) and the Stress Self-Assessment Questionnaire-53 (SSQ-53). These were used to collect general information, mental health status, and stress levels of the subjects. According to the degree of malignant risk, TNs were categorized into high-risk groups (HRG) and low-risk groups (LRG). Differences between the two groups were compared in terms of general information, mental health status scores, and laboratory indicators.
Results: The overall detection rate of TNs was 34.5%, with a significantly higher rate in women. There were significant differences in age and gender between HRG and LRG; The total score of SCL-90 in the HRG was significantly higher than that in LRG (128.78± 45.65 vs 120.59± 31.68, p=0.044); HRG exhibited a higher proportion of positive rates in the somatization (P=0.033) and anxiety (P=0.048) factors of the SCL-90. Among the 10 factors of SCL-90, the scores of somatization (P=0.011), obsessive-compulsive (P=0.010), interpersonal sensitivity (P=0.032), depression (P=0.036) and additional factors (diet and sleep) (P=0.008) in HRG were significantly higher. The results of SSQ-53 suggest that the overall stress level in HRG is higher, and the cognitive stress is significantly higher than that in LRG (P=0.003). Multivariate logistic regression analysis showed that age, gender, and SCL-90 total score were risk factors for high-risk TNs.
Conclusion: High-risk TNs are more common in females and older adults. The existence of high-risk TNs is related to poor mental health status.
Keywords: thyroid nodules, thyroid cancer, mental health, psychological stress, influencing factor
Introduction
With the development of the economy and changes in people’s pace of life, the prevalence of thyroid diseases is gradually increasing and receiving more attention. The thyroid gland is an important endocrine organ in the human body, closely related to metabolism, physical development, and emotions. As a common disease of the endocrine system, thyroid nodules (TNs) are mass lesions formed by the abnormal growth of thyroid cells. The prevalence of TNs is gradually increasing in the general population —up to 60% as documented by high-resolution ultrasonography.1 The prevalence of TNs in mainland China is approximately 32%, with variations across different provinces, notably higher in Beijing.2
![]() |
Table 1 Gender Differences in the Prevalence of TNs |
Previous studies have indicated that the occurrence of TNs is associated with gender, age, iodine, ionizing radiation and genetic factors.3,4 Although most TNs are benign, there is a risk of malignant transformation — very few of these lesions ultimately prove to be malignant (about 10%).5 Thyroid cancer (TC) is the most common endocrine malignancy, accounting for approximately 2.1% of all cancer diagnoses globally, with female patients making up 77% of cases. According to China’s cancer statistics from 2023, the current incidence of TC in China is 14.65 per 100,000 individuals, ranking eighth among all malignant tumors and third among female malignant tumors.6 Between 2005 and 2015, the incidence rate of TC in China increased at an average annual rate of 12.4%, becoming the fastest growing malignant tumor.7 At present, the prevalence of TNs and TC is increasing worldwide, and it is showing a trend of affecting younger populations.8 Therefore, it is essential to investigate the risk factors of TNs and their potential for cancer.
At present, it is believed that excessive psychological pressure and long-term negative emotions such as anxiety and depression may be one of the risk factors for thyroid disease. Some studies have even investigated negative emotions as an independent risk factor for TC.9 However, the precise correlation between psychological factors and TNs (benign or malignant) remains poorly understood. Thyroid diseases have always been closely associated with mental illnesses, with symptoms accompanied by emotional disorders being more common. For instance, hyperthyroidism is prone to emotional issues such as anxiety and depression. Furthermore, studies have found that hyperthyroidism may increase the risk of bipolar disorder.10 The prevalence of psychological negative emotions in patients with Hashimoto’s thyroiditis was high.11 Research showed that psychosocial stress appears to increase the susceptibility to chronic diseases, such as major depressive disorder (MDD) and cancer. Furthermore, chronic psychosocial stress elevates the mortality rate of multiple types of cancer.12 Negative emotions can impair immune function,13 leading to immune dysfunction and subsequently causing chronic inflammation. Chronic inflammation not only affects thyroid function but may also lead to abnormal proliferation of glandular cells, which can progress to the formation of TNs and even malignant transformation.9,14 There is ample clinical and basic research evidence supporting the significant role of inflammation in tumor growth and progression. Recent research on the neurobiology of depression and the pathophysiology of cancer has revealed that there may be common biological and behavioral mechanisms between the two.15
To our knowledge, there are few studies exploring the association between mental health and TNs, as well as the potential impact of psychological state on the risk level of nodules. Therefore, this study collected relevant data from participants who underwent health checks at a tertiary hospital in Beijing. Self-administered questionnaires were used to collect general information, while the Symptom Checklist 90 (SCL-90) and Stress Self-Assessment Questionnaire (SSQ-53) were used to assess psychological status and stress levels, and laboratory values were used to assess physiological status. By analyzing TNs based on their imaging classification, researchers aim to explore the psychological, biochemical, and other factors that may influence the transition of TNs from low-risk to high-risk, promote the prevention of TC, and further improve thyroid health management.
Materials and Methods
Research Objects
This is a large cross-sectional study. Participants were recruited from individuals who underwent health examinations at the Health Management (Physical Examination) Center of Peking University Third Hospital between January 2021 and December 2023.
Requirements for inclusion: (1) Age 18 and above; (2) Completion of thyroid ultrasound; (3) Completion of psychological evaluation. According to the Helsinki Declaration, protocols involving human participants are reviewed and approved by the Institutional Ethics Committee of Peking University Third Hospital (Project number: M2022255). After being fully informed goals and methods of the study, all participants signed an informed consent form and consented to the use of the current health survey data, relevant physical exam results, and laboratory results.
Methods
General Information
A self-made questionnaire was used to collect general data from participants, including age, gender, marital status, etc. All participants completed the questionnaires (including psychological questionnaires).
Thyroid Ultrasonography
The thyroid ultrasound examination is conducted by two registered doctors holding professional ultrasound certificates. Ultrasound was performed using the Resona R9 color Doppler ultrasound examination system (Mindray, Shenzhen, China), equipped with an L15-3 linear array probe (frequency range 3MHz-15MHz). We classified TNs according to the C-TIRADS guidelines.16 (The Chinese Thyroid Imaging Reporting and Data System established through a score-based methodology comprises the following classification categories: Category 1: No intervention required; Category 2: Malignancy risk 0%; Category 3: Malignancy risk <2%; Category 4A: Malignancy risk 2%-10%; Category 4B: Malignancy risk 10%-50%; Category 4C: Malignancy risk 50%-90%; Category 5: Malignancy risk >90%; Category 6: Biopsy-proven malignant nodules).
Mental Health Assessment
The Symptom Checklist 90 (SCL-90)17 was used to assess the participant’s psychosomatic status. The scale consists of 90 items, divided into 10 factors: somatization, obsessive-compulsive, interpersonal sensitivity, depression, anxiety, hostility, phobic anxiety, paranoid ideation, psychoticism, and additional items (mainly sleep and diet conditions). Using a 5-point scale, the higher the score, the worse the health condition. If the total score is ≥160 and/or any factor score is ≥2 (the 10 factors mentioned above, reflecting the characteristics of symptom clusters), the participant’s psychological assessment result is considered positive. According to the comparison of the total score of SCL-90 with the health norm of the Chinese population, a total score range of 90–159 indicates health/sub-health, while a total score of 160 or above indicates abnormal mental health level (160–199 indicates mild, 200–249 indicates moderate, and 250 or above indicates severe). The degree of psychological stress was assessed using the Stress Self-Assessment Questionnaire-53 (SSQ-53). The scale contains 53 questions to assess the level of stress experienced by individuals in the past month, which is roughly divided into four stress factors: physical, emotional, cognitive, and behavioral (0–0.08 points for level 1, 0.09–0.19 points for level 2, 0.2–0.28 points for level 3, 0.29–0.42 points for level 4, 0.43–0.62 points for level 5, 0.63–0.91 points for level 6, 0.92–1.3 points for level 7, 1.31–1.72 points for level 8, 1.73–4 points for level 9, and 1.73–4 points for level 9 with ≥2 points for question 38 and ≥3 points for question 36 or 51 for level 10). The higher the score, the greater the stress. People with a stress level of 7 or above are considered to have a high level of stress, exhibit psychological and physiological symptoms of excessive stress, and need stress management.
Hematology Examination
Collect the elbow vein blood of participants and centrifuge it at 3000 r/min for 15 minutes at 4°C. The SYSMEX XN-2000 fully automated blood analyzer was used for whole blood cell count analysis. The Beckman Coulter AU5800 automatic biochemical analyzer was used to analyze blood biochemistry. Thyroxine, triiodothyronine, free triiodothyronine, thyroid-stimulating hormone, and other thyroid-related markers were measured using a Siemens Atellica analyzer.
Statistical Analysis
All data were analyzed using SPSS 26.0. The two-sample t-test is used to compare inter-group data, which were normally distributed in general data and expressed as mean ± standard deviation (). The Mann–Whitney U-test is used to compare data that do not follow a normal distribution, represented as M (Q1, Q3). The Chi-square test was used to compare groups, and count data were expressed as n (%). All statistical analyses were considered statistically significant when the two-sided p-value was less than 0.05.
Results
General Features and Classification of TNs
Among the participants who underwent health examinations between January 2021 and December 2023, 7645 cases were ultimately included according to the inclusion criteria and data integrity analysis. This included 4051 males (53.0%) and 3594 females (47.0%). The number of people who TNs detected was 2640 (34.5%), including 1250 males (30.9%) and 1390 females (38.7%). The prevalence of TNs in females was significantly higher than that in males (p<0.001). The number of people who underwent total or partial thyroidectomy was 104 (1.4%), including 28 males (0.7%) and 76 females (2.1%) (p<0.001) (Table 1).
According to the C-TIRADS guidelines to classify the malignant risk of TNs, participants with C-TIRADS category 4 and above were classified as a high-risk group (HRG), with a total of 129 cases (1.7%), participants with C-TIRADS category 3 and below (including normal ones) were classified as a low-risk group (LRG), with a total of 7516 cases (98.3%). There were significant differences in age, gender, and marital status between the two groups (Table 2).
![]() |
Table 2 Differences in Demographic Characteristics Between High-Risk Group and Low-Risk Group of TNs |
The SCL-90 Results of the High-Risk Group Showed More Abnormal Psychological States
The total score and average score of SCL-90 in the high-risk group (HRG) were 128.78 ± 45.65 and 1.43 ± 0.51, respectively. These scores were significantly higher than those in the low-risk group (LRG), which had a total score of 120.59 ± 31.68 and a total average score of 1.34 ± 0.35. In the positive items, the proportion of somatization and anxiety items was significantly higher in the HRG (somatization P=0.033, anxiety P=0.048). Among the 10 factors of SCL-90, the HRG exhibited significantly higher scores in somatization (P=0.011), obsessive-compulsive symptoms (P=0.010), interpersonal sensitivity (P=0.032), depression (P=0.036), and additional items (eg diet, sleep) (P=0.008) compared to the LRG. According to the total score, the mental health level of the subjects was divided into abnormal and relatively normal states. No significant difference was found in the proportion of subjects with abnormal mental health status between the HRG and LRG (Table 3).
![]() |
Table 3 Results of Symptom Checklist 90 (SCL-90) in Both Groups |
The High-Risk Group of TNs Showed Higher Psychological Stress
The overall stress level of the HRG was higher, and the cognitive stress score was significantly higher than that of the LRG (P=0.003). According to the stress score, levels 7 and above are considered to have excessive stress. According to this classification, no significant difference was found between the HRG and the LRG (Table 4).
![]() |
Table 4 Results of the Stress Self-Assessment Questionnaire-53 (SSQ-53) in Both Groups |
Physical Examination Results of the Two Groups
By comparing the differences in physical indicators including body mass index (BMI), blood pressure, and laboratory values between HRG and LRG, it was found that compared to LRG, the levels of total cholesterol (P=0.038), thyroxine (P<0.001), and free thyroxine (P<0.001) were significantly elevated in HRG; meanwhile, the levels of thyroid-stimulating hormone (TSH) (P=0.001), triiodothyronine (T3) (P=0.014), free triiodothyronine (FT3) (P<0.001), erythrocytes (P=0.008), hemoglobin (HGB) (P<0.001), uric acid (UA) (P=0.006), and creatinine (Cr) (P=0.001) were significantly reduced (Table 5).
![]() |
Table 5 Differences in Physical Examination Results Between the Two Groups |
Analysis of Risk Factors for High-Risk Nodules
In the multivariate logistic regression analysis, age, gender, marital status, erythrocytes, hemoglobin, total cholesterol, creatinine, uric acid, and SCL-90 total score were used as independent variables, and the presence of high-risk nodules was used as the dependent variable. The results indicated that age (OR=1.060 per year, 95% CI [1.038–1.082], p<0.001), female gender (OR=3.430 vs male, 95% CI [1.738–6.771], p<0.001), and SCL-90 total score (OR=1.006, 95% CI [1.001–1.010], p=0.013) were independently associated with the risk of having high-risk nodules. The model demonstrated good fit (Hosmer-Lemeshow test p>0.05). Age was an independent risk factor for the occurrence of high-risk TNs, with a 6% increase in risk for each additional year of age. Women were significantly more likely to have high-risk nodules than men, with a risk of 3.43 times higher. The SCL-90 total score was an independent factor influencing the occurrence of high-risk TNs, with a 0.6% increase in risk for each additional score (Table 6).
![]() |
Table 6 Multivariate Analysis of Risk Factors for High-Risk Nodules |
Discussion
Current study found that the prevalence of TNs is relatively high. TNs, including potentially malignant nodules, are more common in women. Age is also a risk factor for the development of high-risk nodules. Patients with high-risk nodules tend to have poorer mental health and higher psychological stress, suggesting that poor mental health status may be associated with the deterioration of nodules. Study investigated the impact of physical indicators, including those from routine physical examinations, on TNs and found that age, being female, and poor mental health status (high SCL-90 total score) are independent risk factors for the presence of high-risk TNs.
In recent years, the prevalence of TNs has significantly increased. This survey was conducted at a large comprehensive hospital in Beijing among people over 18 years old who underwent health check-ups. Research shows that the prevalence of TNs in this population is 34.5%, which is consistent with previous survey results.18 According to the literature, the prevalence rate varies in different regions, showing a regional-specific manner in China. The differences may be caused by factors such as age, gender, genetics, living environment, dietary habits, and iodine nutrition status.2,18
In this study, the prevalence of TNs in women was 38.7%, significantly higher than that in men (30.9%). Multivariate analysis results indicated that the probability of high-risk nodules in women was 3.4 times higher than that in men. This is consistent with previous research findings.19,20 Sex hormones play a significant role in this process. Evidence suggests that estrogen receptors are expressed in both normal and malignant thyroid tissues, indicating that estrogen may directly regulate the proliferation and function of human thyroid cells. Furthermore, it can regulate genes involved in the progression of the thyroid cell cycle, potentially contributing to the pathogenesis of TC or the thyroid hyperplasia.21 Meanwhile, research suggests that women are also at a higher risk of developing anxiety, depression, and stress-related disorders, with a likelihood twice that of men.22 This can also partially explain the high comorbidity phenomenon between emotional issues, stress-related diseases, and TNs, as well as the potential common pathological pathways among these diseases.
Current study revealed that the average age of the high-risk TNs patients is higher than that of the low-risk TNs population, indicating that age plays a significant role in regulating the incidence rate of potential malignant TNs. Furthermore, age is an independent risk factor for the emergence of high-risk TNs, with the risk increasing by 6% for every additional year of age. This is consistent with previous research findings.23 The mechanism may be that as age increases, thyroid tissue undergoes degenerative changes, leading to diffuse compensatory hyperplasia of the thyroid gland.24 Recent studies suggest that the age-specific incidence rate curve for malignant nodules is now changing, reaching a peak around the age of 40 or 50, rather than increasing with age.25
Previous studies have indicated that the occurrence of TNs is associated with negative emotions, and negative emotions are also considered as an independent risk factor for TC. Consistent with previous research, current study reveals that subjects in the high-risk nodule group have a higher total score on the SCL-90, indicating a poorer overall mental health status. Furthermore, they exhibit higher scores in factors such as somatization, interpersonal sensitivity, anxiety, depression, obsession-compulsion, and diet and sleep, suggesting that subjects with high-risk nodules experience maladjustment in various aspects of their lives, including emotional, somatic sensations, and social interactions. This includes negative emotional experiences such as depressive symptoms and anxiety spectrum symptoms (including obsession), subjective physical discomfort (somatization), poor diet, poor sleep conditions, and other adverse physical experiences, as well as negative experiences in social life such as discomfort and inferiority in interpersonal relationships (interpersonal sensitivity). Maladjustment is accompanied by increased psychological stress, leading to a decline in overall mental health status. Multivariate analysis reveals that poor mental health status (increased total score on the SCL-90) is an independent risk factor for the presence of high-risk nodules. For every 1-point increase in the total SCL-90 score, the risk increases by 0.6%. Therefore, it is speculated that poor mental health status may be a triggering and exacerbating factor in the development of malignant TNs.
Long term research has found a bidirectional causal relationship between mental health problems and thyroid diseases, such as a positive correlation between anxiety and hypothyroidism, and a positive correlation between autoimmune thyroiditis, hypothyroidism, and recurrent or chronic depression.26 Emotional disorders and thyroid diseases are regulated by the neuroendocrine axis. Chronic stress (including depression and anxiety-related disorders) affects thyroid dysfunction through the cross-action of the hypothalamic-pituitary-adrenal (HPA) and hypothalamic-pituitary-thyroid (HPT) axes. Overactivation of the HPA axis leads to excessive cortisol release, which could inhibit the activity of the HPT axis. This, in turn, can increase susceptibility to anxiety and depression.27 The prolonged secretion of glucocorticoids caused by chronic stress can interfere with the immune system’s response by altering cytokines, inducing low-grade chronic inflammation, and inhibiting the function of immune protective cells. Continuous exposure to specific endocrine-disrupting chemicals (EDCs) has an impact on thyroid development, function, and proliferation, leading to thyroid diseases and potential cancers.28 In summary, thyroid hormone imbalance, chronic inflammation, and endocrine disruptors are all potential risk factors for oxidative stress. Oxidative stress can cause DNA damage, leading to mutations in TC-related genes.29 Studies on cancer subjects have also found that stress appears to affect every stage of tumor progression.30
On the other hand, the mere presence of malignant nodules can easily trigger negative emotions and exert significant psychological pressure. Cancer related concerns persist for several years after the patient’s diagnosis and treatment.31 A survey found that within 2–4 years after diagnosis, 41.0% of patients expressed concerns about death, 43.5% of patients were concerned about the harm of treatment, 54.7% of patients were concerned about their quality of life being compromised, 58.0% of patients were concerned about family risks, and 63.2% were concerned about recurrence.32 20–40% of women express high levels of concern, with younger patients being more concerned about disease recurrence.33 In a study targeting women with cancer, it was found that TC patients are more prone to anxiety and fatigue.34 A survey conducted one year after diagnosis of differentiated TC showed that among 235 patients, 75% expressed concerns about recurrence, and 23% expressed negative views about life.35 Therefore, the symptoms of cancer itself and the emotional issues it triggers could also increase the psychological burden on patients.
To our knowledge, there is limited research on the relationship between mental health status and TNs, whether benign or malignant. This study compares the mental health status of patients with low-risk and high-risk TNs, clearly indicating a significant correlation between high-risk TNs and poor mental health. However, there are still some limitations to this study. Current research is a cross-sectional study, which can only demonstrate the correlation between poor mental health and high-risk TNs, but cannot explore the causal relationship. Next, we will further establish a cohort to explore its deeper association.
Conclusion
This large cross-sectional study found that the prevalence of TNs is relatively high. Both benign and potentially malignant nodules are more common in women. Compared to benign nodules, potentially malignant nodules occur at a higher age. Through the detection of mental health status and psychological stress, it was found that patients with high-risk nodules have poorer mental health and greater psychological stress, manifested as more negative emotions, physical discomfort, and interpersonal tension. This suggests that poor mental health status may be an important factor in the development of malignant nodules. This indicates that we need to pay attention to the mental health status of patients with TNs, so as to make strategic adjustments in preventing the occurrence of malignant nodules and reducing the adverse consequences caused by malignant nodules.
Acknowledgments
This work was supported by the Peking University Third Hospital Health Examination Follow up Queue (NO. IRB00006761-M2022255) and the National Science and Technology Innovation 2030, Noncommunicable Chronic Diseases-National Science and Technology Major Project (Grant No. 2024ZD0524300, 2024ZD0524301).
Disclosure
The authors report no conflicts of interest in this work.
References
1. Grani G, Sponziello M, Pecce V, Ramundo V, Durante C. Contemporary thyroid nodule evaluation and management. J Clin Endocrinol Metab. 2020;105(9):2869–2883. doi:10.1210/clinem/dgaa322
2. Jiang H, Tian Y, Yan W, et al. The prevalence of thyroid nodules and an analysis of related lifestyle factors in Beijing communities. Inter J Environ Res Public Health. 2016;13(4):442. doi:10.3390/ijerph13040442
3. Sutton W, Canner JK, Rooper LM, Prescott JD, Zeiger MA, Mathur A. Is patient age associated with risk of malignancy in a >/=4 cm cytologically benign thyroid nodule? Am J Surg. 2021;221(1):111–116. doi:10.1016/j.amjsurg.2020.05.034
4. Lee YJ, Cho YJ, Heo YJ, et al. Thyroid nodules in childhood‐onset Hashimoto’s thyroiditis: frequency, risk factors, follow‐up course and genetic alterations of thyroid cancer. Clin Endocrinol. 2021;95(4):638–648. doi:10.1111/cen.14490
5. Durante C, Grani G, Lamartina L, Filetti S, Mandel SJ, Cooper DS. The diagnosis and management of thyroid nodules: a review. JAMA. 2018;319(9):914–924. doi:10.1001/jama.2018.0898
6. Zheng R, Zhang S, Zeng H, et al. Cancer incidence and mortality in China, 2016. J Natl Cancer Cent. 2022;2(1):1–9. doi:10.1016/j.jncc.2022.02.002
7. Wang J, Yu F, Shang Y, Ping Z, Liu L. Thyroid cancer: incidence and mortality trends in China, 2005-2015. Endocrine. 2020;68(1):163–173. doi:10.1007/s12020-020-02207-6
8. Francis GL, Waguespack SG, Bauer AJ, et al. Management guidelines for children with thyroid nodules and differentiated thyroid cancer. Thyroid. 2015;25(7):716–759. doi:10.1089/thy.2014.0460
9. Lei Z, He Z, Mei Y. Associations of psychological status and ultrasonic characteristics of thyroid nodules in adults during the COVID-19 pandemic. Front Psychol. 2023;14:1202122. doi:10.3389/fpsyg.2023.1202122
10. Hu LY, Shen CC, Hu YW, et al. Hyperthyroidism and risk for bipolar disorders: a nationwide population-based study. PLoS One. 2013;8(8):e73057. doi:10.1371/journal.pone.0073057
11. Giynas Ayhan M, Uguz F, Askin R, Gonen MS. The prevalence of depression and anxiety disorders in patients with euthyroid Hashimoto’s thyroiditis: a comparative study. Gen Hosp Psychiatry. 2014;36(1):95–98. doi:10.1016/j.genhosppsych.2013.10.002
12. Miller GE, Chen E, Parker KJ. Psychological stress in childhood and susceptibility to the chronic diseases of aging: moving toward a model of behavioral and biological mechanisms. Psychol Bull. 2011;137(6):959–997. doi:10.1037/a0024768
13. Sephton SE, Dhabhar FS, Keuroghlian AS, et al. Depression, cortisol, and suppressed cell-mediated immunity in metastatic breast cancer. Brain Behav Immun. 2009;23(8):1148–1155. doi:10.1016/j.bbi.2009.07.007
14. Ferrari SM, Fallahi P, Elia G, et al. Thyroid autoimmune disorders and cancer. Semin Cancer Biol. 2020;64:135–146. doi:10.1016/j.semcancer.2019.05.019
15. Bortolato B, Hyphantis TN, Valpione S, et al. Depression in cancer: the many biobehavioral pathways driving tumor progression. Cancer Treat Rev. 2017;52:58–70. doi:10.1016/j.ctrv.2016.11.004
16. Zhou J, Yin L, Wei X, et al. 2020 Chinese guidelines for ultrasound Malignancy risk stratification of thyroid nodules: the C-TIRADS. Endocrine. 2020;70(2):256–279. doi:10.1007/s12020-020-02441-y
17. Xin S, Jiang W, Xin Z. Changes in Chinese nurses’ mental health during 1998-2016: a cross-temporal meta-analysis. Stress Health. 2019;35(5):665–674. doi:10.1002/smi.2907
18. Li Y, Jin C, Li J, et al. Prevalence of thyroid nodules in China: a health examination cohort-based study. Front Endocrinol 2021;12:676144. doi:10.3389/fendo.2021.676144
19. Yuk JS, Kim JM. Uterine fibroids increase the risk of thyroid goiter and thyroid nodules. Sci Rep. 2022;12(1):6620. doi:10.1038/s41598-022-10625-x
20. Kang HW, No JH, Chung JH, et al. Prevalence, clinical and ultrasonographic characteristics of thyroid incidentalomas. Thyroid. 2004;14(1):29–33. doi:10.1089/105072504322783812
21. Santin AP, Furlanetto TW. Role of estrogen in thyroid function and growth regulation. J Thyroid Res. 2011;2011:875125. doi:10.4061/2011/875125
22. Azharuddin S, Vital-Daley K, Mustovic V, et al. Mental health in women. Crit Care Nurs Q. 2023;46(4):336–353. doi:10.1097/CNQ.0000000000000471
23. Liang Q, Yu S, Chen S, et al. Association of changes in metabolic syndrome status with the incidence of thyroid nodules: a prospective study in Chinese adults. Front Endocrinol 2020;11:582. doi:10.3389/fendo.2020.00582
24. Kwong N, Medici M, Angell TE, et al. The influence of patient age on thyroid nodule formation, multinodularity, and thyroid cancer risk. J Clin Endocrinol Metab. 2015;100(12):4434–4440. doi:10.1210/jc.2015-3100
25. Pizzato M, Li M, Vignat J, et al. The epidemiological landscape of thyroid cancer worldwide: GLOBOCAN estimates for incidence and mortality rates in 2020. Lancet Diabetes Endocrinol. 2022;10(4):264–272. doi:10.1016/S2213-8587(22)00035-3
26. Fan J, Zhou K, Yu C. Causal relationship between emotional disorders and thyroid disorders: a bidirectional two-sample Mendelian randomization study. Brain Behav. 2025;15(1):e70252. doi:10.1002/brb3.70252
27. Wang M, Wang S, Yuan G, et al. Analysis of risk factors for negative emotions in patients with thyroid nodules: a cross-sectional study. Medicine 2024;103(47):e40548. doi:10.1097/MD.0000000000040548
28. Kyriacou A, Tziaferi V, Stress TM. Thyroid dysregulation, and thyroid cancer in children and adolescents: proposed impending mechanisms. Horm Res Paediatr. 2023;96(1):44–53. doi:10.1159/000524477
29. Angelika Bierhaus JW, Andrassy M, Rohleder N, et al. A mechanism converting psychosocial stress into mononuclear cell activation. Proc Natl Acad Sci USA. 2003;100(4):1920–1925. doi:10.1073/pnas.0438019100
30. Jin Shin YJL K, Ryoul yang Y, Park S, et al. Molecular mechanisms underlying psychological stress and cancer. Curr Pharm Des. 2016;22(16):2389–2402. doi:10.2174/1381612822666160226144025
31. Haymart P, Levin NJ, Haymart MR. The psychosocial impact of thyroid cancer. Curr Opin Endocrinol Diabetes Obes. 2023;30(5):252–258. doi:10.1097/MED.0000000000000815
32. Papaleontiou M, Reyes-Gastelum D, Gay BL, et al. Worry in thyroid cancer survivors with a favorable prognosis. Thyroid. 2019;29(8):1080–1088. doi:10.1089/thy.2019.0163
33. Jackson Levin N, Zhang A, Reyes-Gastelum D, et al. Change in worry over time among Hispanic women with thyroid cancer. J Cancer Surviv. 2022;16(4):844–852. doi:10.1007/s11764-021-01078-8
34. Magnani C, Smith AB, Rey D, et al. Fear of cancer recurrence in young women 5 years after diagnosis with a good-prognosis cancer: the VICAN-5 national survey. J Cancer Surviv. 2023;17(5):1359–1370. doi:10.1007/s11764-022-01193-0
35. Hedman C, Djarv T, Strang P, Lundgren CI. Fear of recurrence and view of life affect health-related quality of life in patients with differentiated thyroid carcinoma: a prospective Swedish population-based study. Thyroid. 2018;28(12):1609–1617. doi:10.1089/thy.2018.0388
© 2025 The Author(s). This work is published and licensed by Dove Medical Press Limited. The
full terms of this license are available at https://www.dovepress.com/terms.php
and incorporate the Creative Commons Attribution
- Non Commercial (unported, 4.0) License.
By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted
without any further permission from Dove Medical Press Limited, provided the work is properly
attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.
Recommended articles
Gut Microbiota Changes and Its Potential Relations with Thyroid Disorders: From Composition to Therapeutic Targets
Yang C, Xiao J, Xu Z, Wang Z
International Journal of General Medicine 2024, 17:3719-3731
Published Date: 26 August 2024